Characteristics and Treatment Sequences of Patients with KRAS G12C, Other KRAS and KRAS-Wild-Type Advanced or Metastatic (AM) Non-Small Cell Lung Cancer (NSCLC) in the French ESME Cohort

被引：0
|
作者：
Girard, Nicolas [1 ]
Perol, Maurice [2 ]
Debieuvre, Didier [3 ]
Lemonnier, Lydie [4 ]
Veillard, Charlotte [5 ]
Caillon, Megane [5 ]
Tzala, Lia [6 ]
Desamericq, Gaelle [7 ]
Audigier-Valette, Clarisse [8 ]
机构：
[1] Inst Curie, Pneumol Thorax Inst, Paris, France
[2] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[3] Grp Hosp Mulhouse Sud Alsace, Dept Pneumol, Mulhouse, France
[4] UNICANCER, Hlth Data & Partnership Dept, Paris, France
[5] Amgen SAS, Boulogne, France
[6] Amgen Ltd, Uxbridge, Middx, England
[7] Amgen SAS, Courbevoie, France
[8] Ctr Hosp St Musse, Dept Pneumol, Toulon, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
787
引用
收藏
页码：342 / 342
页数：1
相关论文
共 50 条
  • [21] KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
    Rosell, Rafael
    Codony-Servat, Jordi
    Gonzalez, Jessica
    Santarpia, Mariacarmela
    Jain, Anisha
    Shivamallu, Chandan
    Wang, Yu
    Gimenez-Capitan, Ana
    Molina-Vila, Miguel A.
    Nilsson, Jonas
    Gonzalez-Cao, Maria
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 195
  • [22] KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
    Park, Sehhoon
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Suh, Beomseok
    Keam, Bhumsuk
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (03): : 514 - 522
  • [23] A retrospective study of the prevalence and clinical outcomes of KRAS G12C mutated advanced non-small cell lung cancer (NSCLC) in Australian patients (pts)
    Markman, B.
    Solomon, B.
    Nott, L. M.
    Roberts-Thomson, R.
    Hughes, B.
    Pavlakis, N.
    Davis, A.
    Brown, L. J.
    Parakh, S.
    Brungs, D.
    Bowyer, S. E.
    Nordman, I.
    Jennens, R.
    Warburton, L.
    Harris, S. J.
    Samuel, E.
    Ramanujam, S.
    Wang, A.
    Dumas, M.
    Gard, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1700 - S1700
  • [24] KRAS G12C mutation associated outcomes among patients with locally advanced non-small cell lung cancer.
    Qian, David
    Behera, Madhusmita
    Steuer, Conor Ernst
    Pakkala, Suchita
    Carlisle, Jennifer W.
    Owonikoko, Taofeek Kunle
    Fischer-Valuck, Benjamin Walker
    Kesarwala, Aparna Hemant
    Bradley, Jeffrey
    Curran, Walter J.
    Ramalingam, Suresh S.
    Higgins, Kristin Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
    Griesinger, F.
    Eberhardt, W.
    Hoffknecht, P.
    Metzenmacher, M.
    Wehler, T.
    Kokowski, K.
    Alt, J.
    Schuette, W.
    Jaenicke, M.
    Fleitz, A.
    Zacharias, S.
    Hipper, A.
    Buller, M.
    Weichert, W.
    Groschek, M.
    von der Heyde, E.
    Rauh, J.
    Dechow, T.
    Sebastian, M.
    Thomas, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 135 - 135
  • [26] Treatment and outcome of a real-world cohort of patients with advanced, non-squamous NSCLC and KRAS mutations with a special focus on KRAS G12C
    Griesinger, F.
    Eberhardt, W. E. E.
    Hoffknecht, P.
    Metzenmacher, M.
    Wehler, T.
    Kokowski, K.
    Alt, J.
    Schuette, W.
    Jaenicke, M.
    Fleitz, A.
    Zacharias, S.
    Hipper, A.
    Buller, M.
    Weichert, W.
    Groschek, M.
    von der Heyde, E.
    Rauh, J.
    Dechow, T.
    Sebastian, M.
    Thomas, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S872 - S872
  • [27] Early Changes in Circulating Cell-Free KRAS G12C Predict Response to Adagrasib in KRAS Mutant Non-Small Cell Lung Cancer Patients
    Paweletz, Cloud P.
    Heavey, Grace A.
    Kuang, Yanan
    Durlacher, Emily
    Kheoh, Thian
    Chao, Richard C.
    Spira, Alexander I.
    Leventakos, Konstantinos
    Johnson, Melissa L.
    Ou, Sai-Hong Ignatius
    Riely, Gregory J.
    Anderes, Kenna
    Yang, Wenjing
    Christensen, James G.
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2023, 29 (16) : 3074 - 3080
  • [28] Divarasib Versus Adagrasib or Sotorasib in Pretreated KRAS G12C+Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Gadgeel, S.
    Rahman, A.
    Osaghae, U.
    Fernando, T. M.
    Lin, M. T.
    Koli, K.
    Meyenberg, C.
    Mathisen, M.
    Skoulidis, F.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S349 - S349
  • [29] Characteristics and Treatment Outcomes in Advanced-Stage Non-Small Cell Lung Cancer Patients with a KRAS G12C Mutation: A Real-World Study
    Illini, Oliver
    Fabikan, Hannah
    Hochmair, Maximilian Johannes
    Weinlinger, Christoph
    Krenbek, Dagmar
    Brcic, Luka
    Setinek, Ulrike
    Terbuch, Angelika
    Absenger, Gudrun
    Konjic, Selma
    Valipour, Arschang
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (14)
  • [30] Sotorasib: A Review in KRAS G12C Mutation-Positive Non-small Cell Lung Cancer
    Lee, Arnold
    TARGETED ONCOLOGY, 2022, 17 (06) : 727 - 733
12345